about
NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granulesGray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3pExtracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.A case report of the Modified Malmö Protocol: an alternative therapeutic approach to refractory chronic idiopathic thrombocytopenic purpura.Case-matched comparison with standard versus reduced intensity conditioning regimen in chronic myeloid leukemia patients.An unusual presentation of plasma cell dyscrasias: cardiac tamponade due to myelomatous infiltration.Turkish Transplant Registry: a comparative analysis of national activity with the EBMT European Activity Survey.Late complications after hematopoietic stem cell transplantation.Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation.Enzyme replacement therapy in type 1 Gaucher disease and a review of the literature.Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans.Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow TransplantationThe effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD).Intramesenteric steroid treatment for steroid- refractory gastrointestinal graft versus host disease.Lymphoproliferative disorders in individuals with chronic hepatitis B and C in the Turkish population.Clinical manifestations of cutaneous graft-versus-host disease after allogeneic haematopoietic cell transplantation: long-term follow-up results in a single Turkish centre.Periodontal status and post-transplantation complications following intensive periodontal treatment in patients underwent allogenic hematopoietic stem cell transplantation conditioned with myeloablative regimen.A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters.Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.Remission of severe aplastic anemia associated with hepatitis B virus infection after viral clearance: potential role of lamivudine.Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies.Effects of replacement fluids on plasma viscosity used for therapeutic plasma exchange.Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): therapy induced changes and effects on survival.Differences in liver pathology and clinical outcome between two patients with hepatitis B virus and graft versus host disease.Mobilization of PBSCs with chemotherapy and recombinant human G-CSF: a randomized evaluation of early vs late administration of recombinant human G-CSF.The impact of methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism on transplant-related variables after allogeneic hematopoietic cell transplantation in patients receiving MTX as GVHD prophylaxis.Adjuvant therapeutic plasma exchange in liver failure: assessments of clinical and laboratory parameters.Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver.The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy.How to calculate the quantity of CD34+ cells infused? A single center cohort study based on actual, ideal or adjusted ideal body weight.Peripheral blood stem cell apheresis for allogeneic transplants: Ibni Sina experience.Therapeutic plasma exchange in a single center: Ibni Sina experience.Hb content-based transfusion policy successfully reduces the number of RBC units transfused.High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation.Erythrocyte antigen and reticulocyte engraftment after allogeneic hematopoietic stem cell transplantation.National survey of hemapheresis practice in Turkey (1998).Malpositioning of Hickman catheters, left versus right sided attempts.Impact of harvest product volume in erythrocyte depletion of allogeneic or autologous bone marrow using COBE spectra.Circulating CD44 and intercellular adhesion molecule-1 levels in low grade non-hodgkin lymphoma and B-cell chronic lymphocytic leukemia patients during interferon-alpha-2a treatment.Nailfold capillary abnormalities are prevalent in sclerodermoid graft-versus-host disease and readily detected with dermatoscopy.
P50
Q24314992-719A19ED-3B5F-4806-8687-1B3922AFE1ABQ24618306-CD5BE780-CB30-4488-A509-67E330E0EC68Q33361080-E4553389-B445-4C2B-8060-1844AC0FC368Q33379740-F0364765-F4A7-40FC-9D8C-310962745141Q33397477-5597F1CC-D00A-4DAE-ACE2-8DDE135B17BBQ34573959-BB0BC660-2B05-4FC3-AE4B-70C725EFC398Q37251039-EEA21A1D-BE21-41F0-977C-C4DE0A0288F0Q37810122-22BFF0DA-5091-40A9-A58A-5CC581418F6AQ37912229-EF1FE9A3-6F74-4D60-A3C4-AC21873D7AD3Q38855309-00160538-7627-45DC-9AAF-AC99A2DEABDEQ39346993-6B46376E-FF95-4E89-A1FE-CA51680EF33BQ40889684-16F0B3E4-51AC-43C2-8D8D-9333867E45D4Q42507006-894C34C1-330A-40F2-A51F-2956EDB5216BQ42970285-F9472460-9319-4D00-BEB3-D9166A6EA87BQ43410546-A2DD4D82-448C-4020-AACC-9BBFE8E611A4Q43493636-3CFAF06A-6767-4590-91AA-944617F0200AQ43685983-A891E48E-EA5F-4E73-BDB0-445CD0FE6108Q44038909-790008D0-76B2-49B2-A9FE-22BDA96D8FB4Q44097225-36CC8E4B-B55D-4363-ACDC-EDA36B9149B1Q44106952-EF8829C3-2EBA-425D-B8E1-9C78FF031D92Q44783623-21F78B97-9363-4ACC-868A-3D257B6BE605Q44979380-40D97525-8422-4749-884D-FEA080CBB655Q45036710-91BE165D-4FD5-4D8D-AED0-D25B26BF5928Q45747170-BC69D39A-9900-4E77-B6FC-D3E8745CDC43Q45929975-34B846BC-2ED6-48FE-8F31-EF0801DA888FQ46512721-63F168BE-B54D-4691-8C1B-80F63FFD75DAQ46698313-2277E577-866D-40DF-A235-A570D7C760E5Q46824252-2F43D025-4E49-4EB1-A363-71C2D93469EFQ47238417-3DCE4C3D-E2E9-412C-8073-17BB33DAB220Q47283683-1947D367-5CFD-440F-B694-66A1BD95122FQ47407902-778C6AE7-FF54-4EDE-8D49-CE667C778CE8Q47407911-27FFE7E0-4F94-460C-BB39-54D7A0A1A575Q47885692-D856B635-212F-4D65-838A-992E5FFF8ED5Q47931203-089BFA1C-2049-4352-AD85-D4CF842CA75AQ49286195-5E4E7BD0-FC4C-4B42-8CEB-DEFA3F11CA29Q50136000-72C9AB90-1EB5-4B79-88AB-FE22FA6A9A5BQ50190446-046FE77C-7EA8-444A-AC9B-C5E2D217FB73Q50977317-2A12C66D-F06C-437E-90A4-7DD987E7C253Q51553401-4B6B68F7-797E-4F58-B3FD-DC8DFBAFFF75Q51578130-C10628C6-BC2A-4ECA-92AF-0C60FE8B21C5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mutlu Arat
@ast
Mutlu Arat
@en
Mutlu Arat
@es
Mutlu Arat
@nl
Mutlu Arat
@sl
type
label
Mutlu Arat
@ast
Mutlu Arat
@en
Mutlu Arat
@es
Mutlu Arat
@nl
Mutlu Arat
@sl
prefLabel
Mutlu Arat
@ast
Mutlu Arat
@en
Mutlu Arat
@es
Mutlu Arat
@nl
Mutlu Arat
@sl
P106
P1153
7004005188
P31
P496
0000-0003-2039-8557